세계의 종양영양학 시장 - 규모, 점유율, 성장 분석 : 암유형별, 영양유형별, 제제별, 유통채널별, 최종사용자별, 지역별 산업예측(2025-2032년)
Oncology Nutrition Market Size, Share, Growth Analysis, By Cancer Type, By Nutrition Type, By Formulation, By Distribution Channel, By End-User, By Region - Industry Forecast 2025-2032
상품코드:1622338
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
종양영양학 시장 규모는 2023년에 22억 2,000만 달러로 평가되었고, 2024년 24억 2,000만 달러에서 2032년에는 47억 8,000만 달러로 성장해 예측기간(2025-2032년) CAGR 8.9%로 성장할 전망입니다.
세계의 종양영양학 시장은 암 이환율의 상승과 암 치료에 있어서의 영양의 중요한 역할에 대한 인식의 높아짐에 힘입어 강력한 성장을 이루고 있습니다. 화학요법이나 방사선요법을 받는 환자가 늘어남에 따라 영양부족이 만연하고, 증상관리, 체중유지, 치료성적 향상을 목적으로 한 전문적인 식사지원의 필요성이 높아지고 있습니다. 게다가 암 리스크의 경감이나 전체적인 건강 증진에 있어서의 영양의 영향력을 둘러싼 의식의 고조가, 시장의 확대를 더욱 뒷받침하고 있습니다. 주요 이해관계자는 연구개발에 적극 투자하고 암환자 특유의 영양요건에 맞춘 혁신적인 제품과 서비스를 발표하고 있으며, 이 진화하는 시장 상황 속에서 성공하기 위한 포지셔닝을 설정합니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
종양영양학 시장 규모 : 암 유형별
시장 개요
소화기 암
폐암
유방암
혈액암
간암
기타
종양 영양학 시장 규모 : 영양 유형별
시장 개요
경장 영양
표준식
질병별 처방
경장 영양
완전정맥영양(TPN)
말초정맥영양(PPN)
종양영양학 시장 규모 : 제제별
시장 개요
분말
액체
정제
종양영양학 시장 규모 : 유통채널별
시장 개요
병원 약국
소매 약국
온라인 약국
종양 영양학 시장 규모 : 최종 사용자별
시장 개요
병원
재택 케어 설정
전문 클리닉
종양영양학 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년 대비 비교(2022-2024)
주요 기업 프로파일
Nestle Health Science(Switzerland)
Abbott Laboratories(USA)
Danone SA(France)
Fresenius Kabi AG(Germany)
B. Braun Melsungen AG(Germany)
Mead Johnson Nutrition Company(USA)
Hormel Foods Corporation(USA)
Meiji Holdings Co., Ltd.(Japan)
Victus, Inc.(USA)
Global Health Products, Inc.(USA)
Nutritional Medicinals, LLC(USA)
Kate Farms(USA)
Ajinomoto Co., Inc.(Japan)
Abbott Nutrition(USA)
Danone Nutricia(Netherlands)
Fresenius SE & Co. KGaA(Germany)
Baxter International Inc.(USA)
Nutritional Resources Inc.(USA)
결론과 권장사항
JHS
영문 목차
영문목차
Oncology Nutrition Market size was valued at USD 2.22 Billion in 2023 and is poised to grow from USD 2.42 Billion in 2024 to USD 4.78 Billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).
The global oncology nutrition market is experiencing robust growth, fueled by the escalating incidence of cancer and the increasing acknowledgment of nutrition's crucial role in cancer care. As more patients undergo chemotherapy and radiation therapy, nutritional deficiencies become prevalent, intensifying the need for specialized dietary support aimed at symptom management, weight maintenance, and better treatment outcomes. Moreover, the rising awareness surrounding nutrition's influence in mitigating cancer risks and enhancing overall health further propels market expansion. Key industry stakeholders are actively investing in research and development to launch innovative oncology nutrition products and services tailored to the unique nutritional requirements of cancer patients, positioning themselves for success in this evolving market landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Oncology Nutrition Market Segmental Analysis
Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Oncology Nutrition Market
A significant driver of the oncology nutrition market is the rising global incidence of cancer, which necessitates effective supportive care. Cancer patients frequently face nutritional deficiencies and weight loss due to both the illness and the adverse effects of treatments like chemotherapy and radiation. As a result, oncology nutrition products and services are crucial for delivering essential nutrients, alleviating side effects, and enhancing the overall health and quality of life for those affected by cancer. The increasing awareness of the importance of nutrition therapy in comprehensive cancer care is fueling the demand for these specialized products and services, shaping the market's growth.
Restraints in the Oncology Nutrition Market
The oncology nutrition market faces a notable restraint due to the elevated costs associated with its products. These items are typically custom-made, incorporating specific nutrients tailored to the distinct dietary requirements of cancer patients. The expenses linked to research, development, manufacturing, and rigorous quality assurance increase their price beyond that of conventional nutritional supplements. Moreover, the necessity for personalized nutrition plans and tailored counseling services further escalates overall costs. Consequently, the high prices may hinder accessibility and affordability, particularly for patients in lower-income areas or those with limited financial resources. This financial barrier can significantly affect patient care and nutritional support.
Market Trends of the Oncology Nutrition Market
A prominent trend in the global Oncology Nutrition market is the increasing focus on personalized nutrition interventions tailored specifically for cancer patients. As the medical community recognizes the pivotal role of nutrition in cancer management and recovery, there is a surge in demand for customized nutritional support that aligns with each patient's individual needs. This approach leverages advanced diagnostic tools, including genetic profiling and biomarker analysis, to pinpoint specific nutritional deficiencies or requirements tied to individual cancer types and treatment protocols. By optimizing nutritional intake, enhancing immune function, and mitigating treatment-related side effects, personalized oncology nutrition aims to significantly improve patients' overall well-being and quality of life, reflecting the broader shift towards precision medicine in oncology care.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Global Oncology Nutrition Market Size by Cancer Type & CAGR (2025-2032)
Market Overview
Gastrointestinal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Liver Cancer
Others
Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2025-2032)
Market Overview
Enteral Nutrition
Standard Formulas
Disease-Specific Formulas
Parenteral Nutrition
Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN)
Global Oncology Nutrition Market Size by Formulation & CAGR (2025-2032)
Market Overview
Powder
Liquid
Tablet
Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Oncology Nutrition Market Size by End-User & CAGR (2025-2032)
Market Overview
Hospitals
Homecare Settings
Specialty Clinics
Global Oncology Nutrition Market Size & CAGR (2025-2032)
North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
US
Canada
Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
Brazil
Rest of Latin America
Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
